3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
8
Leukemia, Myeloid, Acute
8
Multiple Myeloma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
5
Waldenstrom Macroglobulinemia
4
Myeloproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Anemia, Aplastic
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Interventions
Temozolomide
5
Specimen Handling
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
vocimagene amiretrorepvec
1
trametinib
1
dabrafenib
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Outcome Assessment, Health Care
1
Observational Studies as Topic
1
Ketoconazole
1
Irinotecan
1
Heart Rate
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
DNA
1
Craniotomy
1
Carmustine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Sirolimus
×
90 days
×
Clear all
No trials found.